View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Asthma and Respiratory Disorders News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 12, 2023
5 min read
Save

New Jersey caps out-of-pocket inhaler, epinephrine autoinjector costs

New Jersey caps out-of-pocket inhaler, epinephrine autoinjector costs

Gov. Phil Murphy of New Jersey has signed legislation that will cap monthly out-of-pocket prescription costs for epinephrine autoinjectors at $25 and asthma inhalers at $50 in all state-regulated and public employee health insurance plans.

SPONSORED CONTENT
July 12, 2023
38 min listen
Save

The Environment and Autoimmunity, Part 1

The Environment and Autoimmunity, Part 1

This episode delves into the history of the hygiene hypothesis. What do we know about different exposures changing risk for asthma and allergies, and do these exposures have the same protection for autoimmunity?

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
July 07, 2023
1 min read
Save

Cipla recalls six batches of albuterol inhalers for container defect

Cipla recalls six batches of albuterol inhalers for container defect

Six batches of albuterol sulfate inhalation aerosol 90 mcg (200 metered inhalation) were voluntarily recalled by the manufacturer due to container defects that may prevent them from releasing the proper dose.

SPONSORED CONTENT
July 07, 2023
3 min read
Save

Biomarkers predict type 2-high, uncontrolled asthma

Biomarkers predict type 2-high, uncontrolled asthma

Blood eosinophil counts, serum IgE and fractional exhaled nitric oxide may be used to classify patients with T2-high or uncontrolled asthma, according to a study published in Annals of Allergy, Asthma & Immunology.

SPONSORED CONTENT
July 06, 2023
2 min read
Save

Tezepelumab reduces ED visits, hospitalizations in severe, uncontrolled asthma

Tezepelumab reduces ED visits, hospitalizations in severe, uncontrolled asthma

Tezepelumab reduced health care utilization for asthma across all outcomes measured, as well as the severity of exacerbations that required hospitalizations, according to a study published in Annals of Allergy, Asthma & Immunology.

SPONSORED CONTENT
July 05, 2023
2 min read
Save

Persistent rhinitis associated with IgE sensitization, total IgE levels

Persistent rhinitis associated with IgE sensitization, total IgE levels

Persistent rhinitis and the presence of both rhinitis and asthma were associated with IgE sensitization and total IgE levels, according to a study published in Clinical and Translational Allergy.

SPONSORED CONTENT
July 03, 2023
3 min read
Save

Triple therapy improves asthma outcomes compared with pairs of medications

Triple therapy improves asthma outcomes compared with pairs of medications

The use of an inhaled corticosteroid, long-acting beta 2 agonist and long-acting muscarinic antagonist improved asthma outcomes compared with use of just two of those medications, according to a study published in Respiratory Medicine.

SPONSORED CONTENT
June 29, 2023
4 min read
Save

Advantages vary with single- and multiple-inhaler therapies for patients with asthma

Advantages vary with single- and multiple-inhaler therapies for patients with asthma

WASHINGTON — The use of single-inhaler and multiple-inhaler therapies for asthma control as needed offers a variety of pros and cons, according to a presentation at the American Thoracic Society International Conference.

SPONSORED CONTENT
June 29, 2023
3 min read
Save

Patients, physicians overestimate asthma treatment adherence compared with mobile app

Patients, physicians overestimate asthma treatment adherence compared with mobile app

Adherence with asthma medication was lower when recorded by a mobile app compared with patient-reported and physician-reported results, according to a study published in Clinical and Translational Allergy.

SPONSORED CONTENT
June 23, 2023
1 min read
Save

FDA approves generic tiotropium bromide inhalation powder

FDA approves generic tiotropium bromide inhalation powder

The FDA has approved Lupin’s 18 µg capsules of tiotropium bromide inhalation powder, according to a manufacturer-issued press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails